Amgen Inc
AMGN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000318154
In the last 90 days, Amgen Inc insiders filed 0 open-market purchases and 3 sales; 3,168 institutions reported holding it in 13F filings for Q2 2026, worth $161.8B in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $4.11M in total
- 3
- 13F holdersQ2 2026, +56 vs. previous quarter
- 3,168
- 13F valueReported value at the end of Q2 2026
- $161.8B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding AMGN, Q2 2026
No superinvestor reported holding AMGN at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Amgen Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2026 (view filing)7:05 PM ET | Aug 11-13 | 2 days | Khosla RachnaSVP, Business Development | SSale | −3.25K | $414.05 | −$1.35M | −33.7%6.40K after | 2 lots |
| Aug 7, 2026 (view filing)6:47 PM ET | Aug 6 | 1 day | Miller DerekSVP, Human Resources | SSale | −3.89K | $402.54 | −$1.57M | −23.8%12.5K after | 2 lots |
| Aug 7, 2026 (view filing)6:45 PM ET | Aug 6 | 1 day | Grygiel Nancy A.SVP & CCO | SSale | −2.97K | $402.16 | −$1.19M | −28.8%7.34K after | 2 lots |
| May 5, 2026 (view filing) | May 4 | 1 day | Grygiel Nancy A.SVP & CCO | SSale | −1.24K | $323.73 | −$400.5K | −15.0%7.01K after | |
| Mar 2, 2026 (view filing) | Feb 26 | 4 days | Santos EstebanEVP, Operations | SSale | −54.8K | $379.12 | −$20.8M | −41.7%76.6K after | 2 lots |
| Feb 20, 2026 (view filing) | Feb 19 | 1 day | Busch Matthew C.VP, Finance & CAO | SSale | −1.00K | $375.79 | −$375.8K | −22.6%3.42K after | |
| Nov 21, 2025 (view filing) | Nov 20 | 1 day | Grygiel Nancy A.SVP & CCO | SSale | −3.14K | $337.26 | −$1.06M | −30.3%7.22K after | 2 lots |
| Nov 13, 2025 (view filing) | Nov 12 | 1 day | Khosla RachnaSVP, Business Development | SSale | −890 | $336.24 | −$299.3K | −11.2%7.08K after | |
| Nov 13, 2025 (view filing) | Nov 12 | 1 day | Gordon MurdoEVP, Global Commercial Ops | SSale | −6.88K | $336.83 | −$2.32M | −14.1%41.9K after | |
| Aug 22, 2025 (view filing) | Aug 20 | 2 days | Grygiel Nancy A.SVP & CCO | SSale | −1.27K | $296.99 | −$376.3K | −14.9%7.21K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Amgen Inc at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 49,362,016 | $17.9B | 0.27% | +2,261,544+4.8% | Added |
| Vanguard Capital Management LLC | 35,250,101 | $12.8B | 0.27% | +235,869+0.7% | Added |
| State Street Corp | 30,560,537 | $11.1B | 0.33% | +12,0490.0% | Added |
| Capital World Investors | 29,075,329 | $10.5B | 1.24% | −213,014−0.7% | Reduced |
| Invesco Ltd. | 16,320,446 | $5.91B | 0.47% | +434,940+2.7% | Added |
| Geode Capital Management, LLC | 15,696,068 | $5.67B | 0.30% | +265,544+1.7% | Added |
| Charles Schwab Investment Management Inc | 15,034,038 | $5.44B | 0.72% | +2,260,652+17.7% | Added |
| Vanguard Portfolio Management LLC | 14,853,366 | $5.38B | 0.24% | +232,218+1.6% | Added |
| Morgan Stanley | 13,653,692 | $4.94B | 0.26% | −2,182,366−13.8% | Reduced |
| Wells Fargo & Company | 7,235,462 | $2.62B | 0.46% | +147,452+2.1% | Added |